Nasdaq Harp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Harpoon Therapeutics (NASDAQ:HARP – Get Free Report) and LianBio (NASDAQ:LIAN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Profitability This table compares Harpoon Therapeutics and LianBio’s […]

Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Free Report) have received a consensus recommendation of “Hold” from the six analysts that are presently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year […]

Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Free Report) major shareholder Merck & Co., Inc. purchased 21,397,205 shares of the firm’s stock in a transaction on Monday, March 11th. The shares were purchased at an average price of $23.00 per share, with a total value of $492,135,715.00. Following the completion of the acquisition, the insider now […]

Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Free Report) has received a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among […]

Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average […]